Protagenic Therapeutics, Inc.\new Impairment of Long-Lived Assets to be Disposed of
Protagenic Therapeutics, Inc.\new (PTIX) reported Impairment of Long-Lived Assets to be Disposed of of $13.34 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf · last filed 2026-08-19
- Protagenic Therapeutics, Inc.\new impairment of long-lived assets to be disposed of for the quarter ending 2026-06-30 was $13.34K.
- Protagenic Therapeutics, Inc.\new impairment of long-lived assets to be disposed of for the quarter ending 2026-03-31 was $0.00.
- Protagenic Therapeutics, Inc.\new impairment of long-lived assets to be disposed of for the quarter ending 2025-12-31 was $0.00.
- Protagenic Therapeutics, Inc.\new impairment of long-lived assets to be disposed of for fiscal 2026 was $0.00.
| Period end | Impairment of Long-Lived Assets to be Disposed of 3 month | Impairment of Long-Lived Assets to be Disposed of 6 month | Impairment of Long-Lived Assets to be Disposed of 9 month | Impairment of Long-Lived Assets to be Disposed of 12 month |
|---|---|---|---|---|
| 2026-06-30 | $13.34K 10-Q · filed 2026-08-19 | $13.34K derived: sum of 2 quarters · filed 2026-08-19 | $13.34K derived: sum of 3 quarters · filed 2026-08-19 | |
| 2026-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-14 | $0.00 derived: sum of 2 quarters · filed 2026-08-14 | $0.00 10-K · filed 2026-08-14 | |
| 2025-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-03-09 | $0.00 10-Q · filed 2026-03-09 | ||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |